Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns Source: Eur Respir J, 53 (3) 1900135; 10.1183/13993003.00135-2019 Year: 2019
Contemporary issues in pulmonary hypertension Source: Eur Respir Rev 2010 19: 266-271 Year: 2010
Still puzzling about a clear definition of pulmonary arterial hypertension in newborns Source: Eur Respir J, 53 (3) 1900005; 10.1183/13993003.00005-2019 Year: 2019
The new definition of pulmonary hypertension Source: Eur Respir J 2009; 34: 790-791 Year: 2009
Haemodynamic definitions and updated clinical classification of pulmonary hypertension Source: Eur Respir J, 53 (1) 1801913; 10.1183/13993003.01913-2018 Year: 2019
Hemodynamic and clinical relevance of “borderline pulmonary hypertension“ Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010
Is there an obesity paradox in pulmonary arterial hypertension? Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017
Contemporary pathology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020
Pulmonary hypertension: pathophysiology and diagnosis Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007
Re-defining end-points in the assessment of pulmonary hypertension Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015
When is pulmonary hypertension not pulmonary hypertension? Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001
The obesity paradox in pulmonary arterial hypertension: the Scottish perspective Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019 Year: 2019
ERS statement on chronic thromboembolic pulmonary hypertension Source: Virtual Congress 2020 – Breathing disorders and cardiovascular diseases Year: 2020
ERS statement on chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 57 (6) 2002828; 10.1183/13993003.02828-2020 Year: 2021
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature Source: Eur Respir J , 49 (2) 1601792; DOI: 10.1183/13993003.01792-2016 Year: 2017
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Lack correlation between FVC/DLC index and pulmonary hypertension in non sclerodermic patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010